Skip to content

Simultaneously PET/MRI in Prolonged DOC Patients

Relationship Between Simultaneously Acquired Resting-state Regional Cerebral Glucose Metabolism and Functional MRI in DOC: a PET/MR Hybrid Scanner Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04164680
Enrollment
24
Registered
2019-11-15
Start date
2018-01-01
Completion date
2021-01-01
Last updated
2022-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder of Consciousness, FDG-PET, Minimally Conscious State, Rs-fMRI

Keywords

Disorder of Consciousness, Unresponsive wakefulness syndrome, Multimodal Neuroimaging

Brief summary

Recently introduced hybrid PET/MR scanners provide the opportunity to measure simultaneously, and in direct spatial correspondence, both metabolic demand and functional activity of the brain, hence capturing complementary information on the brain's physiological state. Here we exploited PET/MR simultaneous imaging to explore the relationship between the metabolic information provided by resting-state fluorodeoxyglucose-PET (FDG-PET) and fMRI (rs-fMRI) in patients with disorders of consciousness.

Interventions

DIAGNOSTIC_TESTMultimodal Neuroimaging

fludeoxyglucose (FDG-)PET/MR imaging

Sponsors

Hangzhou Normal University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* DOC patients (acute, subacute or chronic period): Coma, UWS and MCS.

Exclusion criteria

* neuromuscular blocking agents or sedative drugs administered within the prior 24 hours; * unstable medical condition; * mental implant in the brain

Design outcomes

Primary

MeasureTime frameDescription
resting-state fMRIWithin 7 daysUse resting-state fMRI to test the functional connectivity
fludeoxyglucose (FDG-)PETWithin 7 daysUseFDG-PET to test the metabolism.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026